2x Blend Tesamorelin (10mg) + Ipamorelin (5mg)
A synergistic GH secretagogue blend combining CJC-1295 (No DAC) with Ipamorelin for dual-pathway GH axis research — GHRH receptor activation plus ghrelin receptor (GHS-R) stimulation.
Mechanism of Action
CJC-1295 activates GHRH receptors; Ipamorelin selectively stimulates GHS-R1a with minimal cortisol/prolactin elevation in research models. Combined protocols explore synergistic GH pulse amplification.
Research Applications
- Dual secretagogue GH axis research
- Comparative single vs. blend protocol studies
- GHS-R and GHRH receptor interaction assays
Specifications
| sequence | CJC-1295 + Ipamorelin blend |
| molecular Weight | Blend — see component COAs |
| appearance | White lyophilized powder |
Reconstitution (Laboratory)
Reconstitute with bacteriostatic water. Confirm component masses via COA.
Storage & Handling
Lyophilized: 2–8 °C. Reconstituted: refrigerate.
Quality Assurance
Every lot undergoes independent third-party HPLC purity analysis, mass spectrometry identity confirmation, and endotoxin testing (<0.5 EU/mg). Certificate of Analysis (COA) is stored against the SKU lot number and available through your research account portal.